Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Morgan

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Canadian Journal of Cardiology|March 1, 1997
Is colour flow imaging needed to exclude clinically significant valvular regurgitation in adult patients undergoing transthoracic echocardiography?J L Cox, B Chan, G M Anderson, et al.
The Canadian Journal of Cardiology|November 1, 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.
Journal of the American College of Cardiology|June 1, 1991
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1993
Waiting for coronary revascularization in Toronto: 2 years' experience with a regional referral officeC D Naylor, C D Morgan, C M Levinton, et al.
Psychiatry Research|August 1, 1983
Plasma measures of beta-endorphin/beta-lipotropin-like immunoreactivity in chronic pain syndrome and psychiatric subjectsJ H Atkinson, E F Kremer, S C Risch, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 1, 2000
Olfactory event-related potentials and aging: normative dataC Murphy, C D Morgan, M W Geisler, et al.
Circulation|August 1, 1994
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic EfficacyJ S Steinberg, J S Hochman, C D Morgan, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoproteinJ L Simpson, S Elias, C D Morgan, et al.
Chest|August 1, 1987
Prevention of acute pulmonary edema after bone marrow transplantationW J Dickout, C K Chan, R H Hyland, et al.
The American Journal of Cardiology|August 15, 1993
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study GroupA Haq, C D Morgan, R F Wilson, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Cardiology|March 1, 1997
Is colour flow imaging needed to exclude clinically significant valvular regurgitation in adult patients undergoing transthoracic echocardiography?J L Cox, B Chan, G M Anderson, et al.
The Canadian Journal of Cardiology|November 1, 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.
Journal of the American College of Cardiology|June 1, 1991
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1993
Waiting for coronary revascularization in Toronto: 2 years' experience with a regional referral officeC D Naylor, C D Morgan, C M Levinton, et al.
Psychiatry Research|August 1, 1983
Plasma measures of beta-endorphin/beta-lipotropin-like immunoreactivity in chronic pain syndrome and psychiatric subjectsJ H Atkinson, E F Kremer, S C Risch, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 1, 2000
Olfactory event-related potentials and aging: normative dataC Murphy, C D Morgan, M W Geisler, et al.
Circulation|August 1, 1994
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic EfficacyJ S Steinberg, J S Hochman, C D Morgan, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoproteinJ L Simpson, S Elias, C D Morgan, et al.
Chest|August 1, 1987
Prevention of acute pulmonary edema after bone marrow transplantationW J Dickout, C K Chan, R H Hyland, et al.
The American Journal of Cardiology|August 15, 1993
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study GroupA Haq, C D Morgan, R F Wilson, et al.
Pageof 10